Company

Eledon Pharmaceuticals, Inc.

Pharmaceutical Manufacturing United States 38 employees

Employees: 38
Contacts: 4
Emails: 4
Phones: 4

eledon.com LinkedIn Crunchbase

Eledon Pharmaceuticals, Inc. Overview

Headquarters: United States
Website: eledon.com
Industry: Pharmaceutical Manufacturing
Employees: 38
Founded: 2020
Funding: 85.0M
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

that is developing therapies to protect and prevent rejection of transplanted organs

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.

Eledon Pharmaceuticals, Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 4; 100.0% coverage

Eledon Pharmaceuticals, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Brooke Hegarty	Director Clinical Operations at Eledon	Newton Centre, Massachusetts, United States	Email Phone
June Lee, Md Faccp	Biotech Executive, Company Builder	San Francisco, California, United States	Email Phone
David-Alexandre "Da" Gros	Chief Executive Officer & Director	San Diego, California, United States	Email Phone
Mary Mcguire		Frederick, Maryland, United States	Email Phone